Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Butorphanol (substance) |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nalbuphine (substance) |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing buprenorphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine (substance) |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 70micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 52.5micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 35micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing opioid receptor partial agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Buprenorphine 400micrograms sublingual tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 2mg sublingual tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride + naloxone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 35micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 52.5micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine 70micrograms/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dezocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dezocine 5mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dezocine 10mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dezocine 15mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dezocine |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Butorphanol tartrate |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine lactate |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine hydrochloride |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norbuprenorphine (substance) |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Buprenorphine hydrochloride (substance) |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nalbuphine hydrochloride |
Is a |
True |
Substance with opioid receptor partial agonist mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|